SNOA
SNOA
NASDAQ · Pharmaceuticals

Sonoma Pharmaceuticals Inc

$1.26
+0.01 (+0.80%)
As of Sep 22, 5:55 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +926.2% upside
Low Target $7.21
Average Target $12.93
High Target $14.12
Current Price $1.26
Current
$1.26
Target
$12.93
$7.21 $12.93 avg $14.12
Scenario Analysis
Bear Case
$7.21
472.2%
Low target
Base Case
$12.93
+926.2%
Avg target
Bull Case
$14.12
+1,020.6%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$4.60
-72.6% from high
52-Week Low
$0.85
+48.2% from low
Target vs 52W High
$12.93
+181.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%